FCN3 and hepatocellular carcinoma: The serum expression level of FCN3 was correlated with the progression of Hepatitis C virus (HCV) cirrhosis to HCC, and was also a biomarker for evaluating the prognosis of HCC after radiofrequency ablation (RFA) and TACE 13-15.